SEC 13F Intelligence

Managers / Q4 2019 · view latest →

MORGENS WATERFALL VINTIADIS & CO INC

CIK 0001016150 · 1270 AVENUE OF THE AMERICAS, SUITE 214, NEW YORK, NY, 10020 · 2122184100

Reported Value
$147M
Q4 2019
Positions
50
Filings on Record
29
2019–present window
Filed
Feb 14, 2020
original filing

Summary

Morgens Waterfall Vintiadis & Co Inc reported $147M in U.S.-listed holdings across 50 positions for Q4 2019.

Its largest position, MSFT, represents 5.3% of the portfolio.

Compared with Q3 2019, the fund opened 5 new positions and exited 8.

Portfolio Metrics

Turnover
+20.3%
vs prior filed quarter
Top-10 Concentration
+40.5%
share of reported value
Largest Position
+5.3%
Microsoft
New / Exited
5 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $140MQ1 ’19Q2 ’19: $145MQ3 ’19: $130MQ4 ’19: $147MQ1 ’20: $107MQ1 ’20Q2 ’20: $156MQ3 ’20: $175MQ4 ’20: $185MQ1 ’21: $180MQ1 ’21Q2 ’21: $196MQ3 ’21: $194MQ4 ’21: $186MQ1 ’22: $159MQ1 ’22Q2 ’22: $106MQ3 ’22: $91MQ4 ’22: $115MQ1 ’23: $122MQ1 ’23Q2 ’23: $141MQ3 ’23: $124MQ4 ’23: $135MQ1 ’24: $145MQ1 ’24Q2 ’24: $131MQ3 ’24: $129MQ4 ’24: $131MQ1 ’25: $88MQ1 ’25Q2 ’25: $136MQ3 ’25: $146MQ4 ’25: $137MQ1 ’26: $81MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 95.1%Other: 2.9%ADR: 1.3%REIT: 0.7%
  • Common Stock · 95.1% · $140M
  • Other · 2.9% · $4M
  • ADR · 1.3% · $2M
  • REIT · 0.7% · $974,000

Quarter-over-Quarter Changes full breakdown →

vs Q3 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ELDORADO RESORTS INCNEW+80.0K80.0K+$5M$5M
VIACOMCBS INCNEW+88.0K88.0K+$4M$4M
ESPRESPERION THERAPEUTICS INC NENEW+20.0K20.0K+$1M$1M
AGIOAGIOS PHARMACEUTICALS INCNEW+21.0K21.0K+$1M$1M
NBIXNEUROCRINE BIOSCIENCES INCNEW+9.0K9.0K+$967,000$967,000
ADBEADOBE INCADDED+11.0K12.7K+$4M$4M
METAFACEBOOK INCADDED+15.0K17.7K+$3M$4M
THERAPEUTICSMD INCADDED+138.0K250.0K+$198,000$605,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2019

48 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MSFTMICROSOFT CORPhistory →COM5.35%$8M49.9K
2NVDANVIDIA CORPhistory →COM4.56%$7M28.6K
3LULULULULEMON ATHLETICA INChistory →COM4.45%$7M28.3K
4REATA PHARMACEUTICALS INCCL A3.97%$6M28.6K
5ASMLASML HOLDING N Vhistory →N Y REGISTRY SHS3.96%$6M19.7K
6NFLXNETFLIX INChistory →COM3.87%$6M17.6K
7AMZNAMAZON COM INChistory →COM3.80%$6M3.0K
8AMATAPPLIED MATLS INChistory →COM3.69%$5M89.0K
9OKTAOKTA INChistory →CL A3.44%$5M43.9K
10TTDTHE TRADE DESK INChistory →COM CL A3.37%$5M19.1K
11BBYBEST BUY INChistory →COM3.30%$5M55.4K
12ELDORADO RESORTS INCCOM3.24%$5M80.0K
13TTWOTAKE-TWO INTERACTIVE SOFTWARhistory →COM3.14%$5M37.7K
14AMDADVANCED MICRO DEVICES INChistory →COM3.12%$5M100.0K
15ZYNGA INCCL A3.04%$4M730.0K
16ADBEADOBE INChistory →COM2.85%$4M12.7K
17WMTWALMART INChistory →COM2.79%$4M34.5K
18SHOPSHOPIFY INChistory →CL A2.70%$4M10.0K
19DPZDOMINOS PIZZA INChistory →COM2.65%$4M13.3K
20VIACOMCBS INCCL B2.51%$4M88.0K
21METAFACEBOOK INChistory →CL A2.47%$4M17.7K
22WYNNWYNN RESORTS LTDhistory →COM2.41%$4M25.5K
23ATLASSIAN CORP PLCCL A2.29%$3M28.0K
24EHTHEHEALTH INChistory →COM2.28%$3M35.0K
25VVISA INChistory →COM CL A1.65%$2M12.9K
26ADMAADMA BIOLOGICS INChistory →COM1.63%$2M600.0K
27UNHUNITEDHEALTH GROUP INChistory →COM1.38%$2M6.9K
28MAMASTERCARD INChistory →CL A1.32%$2M6.5K
29MDTMEDTRONIC PLChistory →SHS1.16%$2M15.0K
30ILMNILLUMINA INChistory →COM1.13%$2M5.0K
31TMOTHERMO FISHER SCIENTIFIC INChistory →COM1.10%$2M5.0K
32ESPRESPERION THERAPEUTICS INC NECOM0.81%$1M20.0K
33HRTXHERON THERAPEUTICS INCCOM0.80%$1M50.0K
34AGIOAGIOS PHARMACEUTICALS INCCOM0.68%$1M21.0K
35NBIXNEUROCRINE BIOSCIENCES INCCOM0.66%$967,0009.0K
36LABORATORY CORP AMER HLDGSCOM NEW0.64%$947,0005.6K
37AZNNASTRAZENECA PLCSPONSORED ADR0.44%$643,00012.9K
38JPMJPMORGAN CHASE & COCOM0.43%$638,0004.6K
39CRSPCRISPR THERAPEUTICS AGNAMEN AKT0.41%$609,00010.0K
40THERAPEUTICSMD INCCOM0.41%$605,000250.0K
41MRKMERCK & CO INCCOM0.39%$568,0006.2K
42MGPMGM GROWTH PPTYS LLCCL A COM0.36%$534,00017.3K
43BABOEING COCOM0.33%$489,0001.5K
44BPBP PLCSPONSORED ADR0.32%$473,00012.5K
45ROYAL DUTCH SHELL PLCSPON ADR B0.32%$467,0007.8K
46EDITEDITAS MEDICINE INCCOM0.30%$444,00015.0K
47VICIVICI PPTYS INCCOM0.30%$440,00017.2K
48CLLSCELLECTIS S ASPONSORED ADS0.20%$291,00017.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$81M14May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$137M23Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$146M22Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$136M21Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$88M17May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$131M22Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$129M24Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$131M23Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$145M36May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$135M34Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$124M27Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$141M34Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$122M31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$115M39Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$91M31Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$106M28Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$159M26May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$186M27Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$194M30Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$196M31Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$180M34May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$185M29Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$175M29Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$156M31Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$107M30May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$147M50Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$130M51Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$145M55Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$140M56May 15, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.